Cas:96057-59-9 ethyl 3-oxo-3-quinolin-2-ylpropanoate manufacturer & supplier

We serve Chemical Name:ethyl 3-oxo-3-quinolin-2-ylpropanoate CAS:96057-59-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

ethyl 3-oxo-3-quinolin-2-ylpropanoate

Chemical Name:ethyl 3-oxo-3-quinolin-2-ylpropanoate
CAS.NO:96057-59-9
Synonyms:2-ethoxycarbonylmethylcarbonylquinoline;3-oxo-3-quinolin-2-yl-propionic acid ethyl ester
Molecular Formula:C14H13NO3
Molecular Weight:243.25800
HS Code:2933499090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:56.26000
Exact Mass:243.09000
LogP:2.37070

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-ethoxycarbonylmethylcarbonylquinoline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-oxo-3-quinolin-2-yl-propionic acid ethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-oxo-3-quinolin-2-yl-propionic acid ethyl ester Use and application,3-oxo-3-quinolin-2-yl-propionic acid ethyl ester technical grade,usp/ep/jp grade.


Related News: Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms. ethyl 3-oxo-3-quinolin-2-ylpropanoate manufacturer An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D. ethyl 3-oxo-3-quinolin-2-ylpropanoate supplier The patient, who arrived from Wuhan, is ��stable and under medical care,�� the ministry said in a statement, adding there is ��no cause for concern�� for the public. ethyl 3-oxo-3-quinolin-2-ylpropanoate vendor An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D. ethyl 3-oxo-3-quinolin-2-ylpropanoate factory The patient, who arrived from Wuhan, is ��stable and under medical care,�� the ministry said in a statement, adding there is ��no cause for concern�� for the public.